Sparkle 发表于 2025-3-21 20:01:04

书目名称New Therapeutic Targets in Rheumatoid Arthritis影响因子(影响力)<br>        http://figure.impactfactor.cn/if/?ISSN=BK0665854<br><br>        <br><br>书目名称New Therapeutic Targets in Rheumatoid Arthritis影响因子(影响力)学科排名<br>        http://figure.impactfactor.cn/ifr/?ISSN=BK0665854<br><br>        <br><br>书目名称New Therapeutic Targets in Rheumatoid Arthritis网络公开度<br>        http://figure.impactfactor.cn/at/?ISSN=BK0665854<br><br>        <br><br>书目名称New Therapeutic Targets in Rheumatoid Arthritis网络公开度学科排名<br>        http://figure.impactfactor.cn/atr/?ISSN=BK0665854<br><br>        <br><br>书目名称New Therapeutic Targets in Rheumatoid Arthritis被引频次<br>        http://figure.impactfactor.cn/tc/?ISSN=BK0665854<br><br>        <br><br>书目名称New Therapeutic Targets in Rheumatoid Arthritis被引频次学科排名<br>        http://figure.impactfactor.cn/tcr/?ISSN=BK0665854<br><br>        <br><br>书目名称New Therapeutic Targets in Rheumatoid Arthritis年度引用<br>        http://figure.impactfactor.cn/ii/?ISSN=BK0665854<br><br>        <br><br>书目名称New Therapeutic Targets in Rheumatoid Arthritis年度引用学科排名<br>        http://figure.impactfactor.cn/iir/?ISSN=BK0665854<br><br>        <br><br>书目名称New Therapeutic Targets in Rheumatoid Arthritis读者反馈<br>        http://figure.impactfactor.cn/5y/?ISSN=BK0665854<br><br>        <br><br>书目名称New Therapeutic Targets in Rheumatoid Arthritis读者反馈学科排名<br>        http://figure.impactfactor.cn/5yr/?ISSN=BK0665854<br><br>        <br><br>

驾驶 发表于 2025-3-21 22:13:19

Yoshiyuki Ohsugi,Tadamitsu Kishimotoungen PRANDTLS, wenn er im damaligen Institut für Angewandte Mechanik am Leinekanal in Göttingen immer und immer wieder Strömungen im Wassertank beobachtete und dabei häufig genug Ort und Zeit vergaß. Auch war es seine Art, sich von seinen Überlegungen und Rechnungen­ selbst den Zwischenrechnungen - Zeichnung978-3-662-01078-5978-3-662-01077-8

形容词 发表于 2025-3-22 03:50:52

http://reply.papertrans.cn/67/6659/665854/665854_3.png

苦涩 发表于 2025-3-22 07:08:06

http://reply.papertrans.cn/67/6659/665854/665854_4.png

extinct 发表于 2025-3-22 10:18:45

Co-stimulatory pathways in the therapy of rheumatoid arthritis,on protein combining cytotoxic T lymphocyte antigen 4 (CTLA4) and a portion of the Fc domain of human IgG1, has been approved in the United States and the European Union for the treatment of RA. Abatacept may modulate the T cell or the APC to produce several different outcomes within the joint, incl

最初 发表于 2025-3-22 16:07:41

,Immunobiology of IL-6 — Tocilizumab (humanised anti-IL-6 receptor antibody) for the treatment of rh this therapy has also proved quite effective at improving fever, fatigue and anaemia. No serious adverse events have been reported. At present, several international clinical studies of TCZ are ongoing in more than 4000 patients with active RA in 41 countries. The results are continuing to confirm

清洗 发表于 2025-3-22 19:08:17

http://reply.papertrans.cn/67/6659/665854/665854_7.png

免除责任 发表于 2025-3-22 22:31:31

Role of IL-18 in inflammatory diseases,ivities and has been shown to be safe in patients. Other options for reducing IL-18 activities are inhibitors of capsase-1, human monoclonal antibodies to IL-18, soluble IL-18 receptors and anti-IL-18 receptor monoclonal antibodies.

Precursor 发表于 2025-3-23 01:53:06

Chemokines and chemokine receptors,ptors. Today, most data in this field are obtained from experimental models of arthritis; however, results of some human trials have also become available. Thus, it is possible that a number of specific chemokine and chemokine receptor antagonists will be administered to arthritis patients in the ne

Occupation 发表于 2025-3-23 07:39:22

Targeting the epigenetic modifications of synovial cells, and infectious agents. So far, these factors have been studied almost exclusively as separate agents. However, gene transcription might be affected by ageing and environmental effects (such as nutrition and infections) — without changes in the nucleotide sequence of the underlying DNA. These patter
页: [1] 2 3 4 5
查看完整版本: Titlebook: New Therapeutic Targets in Rheumatoid Arthritis; Paul-Peter Tak Book 2009 Birkhäuser Basel 2009 Arthritis.Chemokine.Drug Target.Interleuki